Brandi H, Schneider S, Ryttig L. Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s320. Available from: https://jofskin.org/33014/index.php/skin/article/view/2401